Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$208M |
| 2 |
Lowe's Companies
LOW
|
+$198M |
| 3 |
American Tower
AMT
|
+$161M |
| 4 |
Lennar Class A
LEN
|
+$150M |
| 5 |
British American Tobacco
BTI
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$208M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$177M |
| 3 |
Crown Castle
CCI
|
+$168M |
| 4 |
Walmart Inc
WMT
|
+$167M |
| 5 |
Entergy
ETR
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.75% |
| 2 | Technology | 13.18% |
| 3 | Healthcare | 11.51% |
| 4 | Industrials | 10.45% |
| 5 | Consumer Discretionary | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARCH
676
DELISTED
Arch Resources, Inc.
ARCH
| $24.4M | 0.04% |
339,952
-189,671
| -36% | -$14.2M |
|
|
ARNA
677
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $24.4M | 0.04% |
955,250
+269,725
| +39% | +$6.19M |
|
678
AtriCure
ATRC
$2.51B
| $24.3M | 0.04% |
1,088,363
+558,536
| +105% | +$12.6M |
|
679
Baxter International
BAX
$13.7B
| $24.3M | 0.04% |
387,395
-490,799
| -56% | -$30.3M |
|
|
KS
680
DELISTED
KapStone Paper and Pack Corp.
KS
| $24.3M | 0.04% |
1,129,120
-757,411
| -40% | -$16.8M |
|
|
CAVM
681
DELISTED
Cavium, Inc.
CAVM
| $24.1M | 0.04% |
366,012
-211,530
| -37% | -$13.4M |
|
|
NYRT
682
DELISTED
New York REIT, Inc.
NYRT
| $24.1M | 0.04% |
307,397
-19,718
| -6% | -$1.64M |
|
|
BWLD
683
DELISTED
Buffalo Wild Wings, Inc.
BWLD
| $24.1M | 0.04% |
228,053
+95,412
| +72% | +$10.6M |
|
|
POT
684
DELISTED
Potash Corp Of Saskatchewan
POT
| $24.1M | 0.04% |
1,251,231
+273,051
| +28% | +$4.87M |
|
685
Encompass Health
EHC
$11.9B
| $24.1M | 0.04% |
652,452
-451,865
| -41% | -$16.1M |
|
686
Charles River Laboratories
CRL
$14.3B
| $24M | 0.04% |
221,937
-1,006,102
| -82% | -$103M |
|
|
PTLA
687
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $24M | 0.04% |
443,582
+192,641
| +77% | +$11.3M |
|
|
GHDX
688
DELISTED
Genomic Health, Inc.
GHDX
| $23.9M | 0.04% |
746,003
+422,438
| +131% | +$13.3M |
|
689
Ryder
R
$9.39B
| $23.7M | 0.04% |
280,660
+155,872
| +125% | +$11.8M |
|
690
Apple Hospitality REIT
APLE
$3.92B
| $23.7M | 0.04% |
1,254,390
+297,497
| +31% | +$5.45M |
|
|
KEM
691
DELISTED
KEMET Corporation
KEM
| $23.7M | 0.04% |
1,119,758
+678,860
| +154% | +$12.8M |
|
692
Open Text
OTEX
$5.95B
| $23.7M | 0.04% |
732,641
+635,319
| +653% | +$20.6M |
|
693
Cencora
COR
$61.8B
| $23.6M | 0.04% |
+284,884
| New | +$24.2M |
|
694
Targa Resources
TRGP
$63.1B
| $23.5M | 0.04% |
497,299
+482,388
| +3,235% | +$21.9M |
|
695
Cracker Barrel
CBRL
$1.3B
| $23.5M | 0.04% |
155,131
+153,793
| +11,494% | +$23.5M |
|
|
RPAI
696
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $23.5M | 0.04% |
1,789,673
+68,422
| +4% | +$896K |
|
697
Antero Resources
AR
$11.7B
| $23.5M | 0.04% |
1,179,822
+865,880
| +276% | +$17.4M |
|
698
Verisk Analytics
VRSK
$24.7B
| $23.4M | 0.04% |
281,250
+173,711
| +162% | +$14.4M |
|
699
MiMedx Group
MDXG
$622M
| $23.4M | 0.04% |
1,967,244
+1,473,206
| +298% | +$21.8M |
|
|
HDP
700
DELISTED
Hortonworks, Inc.
HDP
| $23.3M | 0.04% |
1,376,477
+15,957
| +1% | +$240K |
|
Similar funds
Israel Englander's Q3 2017 Portfolio in Review
As of Q3 2017, Israel Englander held 4,198 positions worth $65.6B, up 17% from $56.1B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.
Israel Englander deployed $6.37B of net new capital in Q3 2017, opening 794 new positions and adding to 1,441 existing holdings. Its largest new stake was Northern Trust: 1,591,041 shares worth $146M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $208M trimmed.
- Israel Englander's largest Q3 2017 buy was Northern Trust: 1,591,041 shares worth $146M.
- Israel Englander added most to Salesforce in Q3 2017, an estimated $208M increase.
- Israel Englander's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $208M.
- Israel Englander fully exited CONCHO RESOURCES INC. in Q3 2017, selling an estimated $177M.
- Israel Englander's ten largest holdings make up 7.8% of its $65.6B portfolio in Q3 2017.
- Israel Englander opened 794 new positions and closed 737 in Q3 2017.
- Israel Englander's portfolio value rose 17% quarter-over-quarter to $65.6B.
Based on Millennium Management's 13F filing for Q3 2017, filed 14 Nov 2017.